Israel-based generic drugs multinational blames single former employee for striking agreements with competitors that limited competition between 2013-2015

Health Ministry panel that probed case of Liron Jazatti, 19, who died after taking dipyrone, finds it's 'impossible to link the incident to taking the drug'

Optalgin, available over the counter in Israel but restricted elsewhere, known to cause dangerous side effects that can lead to death

Company says it created its own mini-grid with solar panels everywhere and switched its fleet to all-electric, as other firms also eye ways to go net zero on carbon emissions

AION Labs, a Rehovot-based consortium formed by Pfizer, Merck, AstraZeneca, Teva and others, sets up company that will help drug firms improve chances of success in clinical trials

Generic drugmaker says it agreed to contribute sum in cash and medications to states, local governments and tribes for its role in epidemic

Affiliate of Israel pharmaceutical giant says settling federal lawsuit is a step toward getting life-saving treatment to addicts, but doesn't admit liability or wrongdoing

In latest settlement, like past ones, US subsidiary of Israeli generic drugmaker to provide over $84m worth of treatment medicines

The research has been snapped up by pharmaceutical giant Teva, and according to the lead author could mean an ‘arsenal of new drugs’

Agreement will see US subsidiary of Israeli generic drugmaker also provide over $78m worth of treatments that aid in addiction treatment and prevention